Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:48 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Samsara BioCapital L.P. | 3,281,766 4.980% | 501,505 (+18.04%) | View |
| 2024-11-14 5:45 pm Purchase | 13G | CARGO Therapeutics Inc. CRGX | Samsara BioCapital L.P. | 4,415,689 9.600% | 294,000 (+7.13%) | View |
| 2024-11-04 4:15 pm Purchase | 13G | Septerna Inc. SEPN | Samsara BioCapital L.P. | 2,768,520 6.200% | 2,768,520 (New Position) | View |
| 2024-10-11 4:15 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Samsara BioCapital L.P. | 824,155 6.500% | 824,155 (New Position) | View |
| 2024-10-07 8:59 pm Sale | 13D | Scholar Rock Holding Corp SRRK | Samsara BioCapital L.P. | 6,757,255 8.300% | -1,121,047 (-14.23%) | View |
| 2024-08-27 4:20 pm Purchase | 13D | ALUMIS INC ALMS | Samsara BioCapital L.P. | 3,266,498 6.900% | 3,266,498 (New Position) | View |
| 2024-04-25 8:39 pm Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | Samsara BioCapital L.P. | 2,442,352 6.400% | 2,442,352 (New Position) | View |
| 2024-03-29 4:06 pm Purchase | 13D | NKARTA INC NKTX | Samsara BioCapital L.P. | 3,768,035 5.400% | 900,000 (+31.38%) | View |
| 2024-03-25 8:42 pm Purchase | 13G | LENZ THERAPEUTICS INC LENZ | Samsara BioCapital L.P. | 1,213,865 4.800% | 1,213,865 (New Position) | View |
| 2024-03-05 7:52 pm Purchase | 13D | vTv Therapeutics Inc. VTVT | Samsara BioCapital L.P. | 265,620 10.400% | 265,620 (New Position) | View |
| 2024-02-14 4:19 pm Sale | 13G | Rain Oncology Inc. RAIN | Samsara BioCapital L.P. | 0 0.000% | -2,260,652 (Position Closed) | View |
| 2024-02-14 4:16 pm Purchase | 13G | NEUROGENE INC NGNE | Samsara BioCapital L.P. | 1,282,563 9.990% | 1,282,563 (New Position) | View |
| 2024-02-12 4:48 pm Purchase | 13D | Mineralys Therapeutics Inc. MLYS | Samsara BioCapital L.P. | 5,092,027 10.300% | 570,222 (+12.61%) | View |
| 2023-12-26 5:19 pm Purchase | 13D | Syros Pharmaceuticals Inc. SYRS | Samsara BioCapital L.P. | 2,515,523 9.500% | 909,977 (+56.68%) | View |
| 2023-12-18 5:14 pm Purchase | 13G | IO BIOTECH INC IOBT | Samsara BioCapital L.P. | 3,640,015 5.500% | 3,640,015 (New Position) | View |
| 2023-11-22 4:15 pm Sale | 13D | CHINOOK THERAPEUTICS INC. KDNY | Samsara BioCapital L.P. | 0 0.000% | -5,181,557 (Position Closed) | View |
| 2023-11-21 4:15 pm Purchase | 13G | CARGO Therapeutics Inc. CRGX | Samsara BioCapital L.P. | 4,121,689 10.700% | 4,121,689 (New Position) | View |
| 2023-10-20 4:15 pm Purchase | 13D | Syros Pharmaceuticals Inc. SYRS | Samsara BioCapital L.P. | 1,605,546 7.500% | 1,605,546 (New Position) | View |
| 2023-10-18 5:27 pm Purchase | 13D | Scholar Rock Holding Corp SRRK | Samsara BioCapital L.P. | 7,878,302 11.000% | 2,202,226 (+38.80%) | View |
| 2023-08-25 4:15 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Samsara BioCapital L.P. | 2,780,261 5.600% | 2,780,261 (New Position) | View |